2025 annual financial data
Lantern Pharma 2025 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -17,978,494 USD and net income was -17,119,438 USD.
Operating cash flow was -15,676,980 USD.
Get free Lantern Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,978,494 USD
- Net income
- -17,119,438 USD
- Operating cash flow
- -15,676,980 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Lantern Pharma financial years